| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |